AI reads myeloma cells to predict hidden genetic risks
NCT ID NCT07410403
First seen Feb 16, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study uses artificial intelligence to examine the shape and structure of individual myeloma cells from bone marrow samples. The goal is to predict certain genetic abnormalities that help doctors understand the severity of the disease. The approach aims to make testing faster, cheaper, and more accurate than current methods. About 10 people with multiple myeloma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 410071, China
Conditions
Explore the condition pages connected to this study.